« Previous
Next »
Cardiovascular Revascularization Medicine
Volume 8, Issue 4
, Pages 243-247
, October 2007
Stent thrombosis following drug-eluting stent implantation. A single-center experience
References
- . A randomized comparison of a sirolimus eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773–1780
- . Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315–1323
- . The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol. 2004;43:1110–1115
- . Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet. 2003;362:1093–1099
- . Three-year clinical follow-up of the unrestricted use of sirolimus-eluting stents as part of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. Am J Cardiol. 2006;98:895–901
- . A Pooled Analysis of Data Comparing Sirolimus-Eluting Stents with Bare-Metal Stents. N Engl J Med. 2007;356:989–997
- . Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356:1020–1029
- . Late stent thrombosis: considerations and practical advice for the use of drug-eluting stents: a report from the Society for Cardiovascular Angiography and Interventions Drug-Eluting Stent Task Force. Catheter Cardiovasc Interv. 2007;69:327–333
- . Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry. Circulation. 2006;113:1434–1441
- . Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126–2130
- . Resistance to clopidogrel: a review of the evidence. J Am Coll Cardiol. 2005;45:1157–1164
- . Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol. 2006;48:2584–2591
- . Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007;356:998–1008
- . Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007;356:1030–1039
- . Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol. 2006;47:175–181
- . Long-term outcomes after management of restenosis or thrombosis of drug-eluting stents. J Am Coll Cardiol. 2007;49:181–184
- . Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48:193–202
- . Late stent thrombosis in the absence of prior intracoronary brachytherapy. Catheter Cardiovasc Interv. 2002;55:142–147
- . Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol. 2005;45:995–998
- . Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. Am J Med. 2006;119:1056–1061
PII: S1553-8389(07)00257-6
doi: 10.1016/j.carrev.2007.07.001
© 2007 Elsevier Inc. All rights reserved.
« Previous
Next »
Cardiovascular Revascularization Medicine
Volume 8, Issue 4
, Pages 243-247
, October 2007
